Community testing of SARS-CoV-2 protein markers

Grant number: 2020-04451

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $228,602.82
  • Funder

    Vinnova
  • Principal Investigator

    N/A

  • Research Location

    Sweden
  • Lead Research Institution

    KTH Royal Institute of Technology
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Purpose and goal The purpose of this project is to screen for circulating proteins related to SARS-CoV-2 infection. The aim is to validate protein marker panels on home-sampled microsamples and to identify protein markers that show past infection of SARS-CoV-2, using a single drop of blood. Expected results and effects We expect to be able to demonstrate the use of home sampling to screen for hundreds of protein markers from a drop of blood. Demonstrating the possibility of biomarker monitoring of home-sampled dried blood spot samples with the Olink panel opens up many new possibilities for screening populations for various diseases. Here we will demonstrate this with respect to SARS-CoV-2 but the future possibilities are potentially enormous as this allows screening of hundreds of proteins from a single drop of blood. Planned approach and implementation We will collect 1000 samples from patients in primary care as well as other volunteers and 1) screen for circulating protein markers related to infection of the new coronavirus. 2) Validate the use of Olink´s protein panels on home-sampled dried blood stains.

Publicationslinked via Europe PMC

Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections.